Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

324 ARTÍCULOS , VIENDO DEL 211 AL 225

Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures

Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG, Aisen P; Alzheimer’s Disease Cooperative Study.

Arch Neurol. 2012 Jul;69(7):836-41. doi: 10.1001/archneurol.2012.85.

Relevance of in vivo neurophysiological biomarkers for mild cognitive impairment and Alzheimer's disease

Yamasaki T, Horie S, Muranaka H, Kaseda Y, Mimori Y, Tobimatsu S.

J Alzheimers Dis. 2012;31 Suppl 3:S137-54. doi: 10.3233/JAD-2012-112093.

Brain imaging in Alzheimer disease

Johnson KA, Fox NC, Sperling RA, Klunk WE.

Cold Spring Harb Perspect Med. 2012 Apr;2(4):a006213. doi: 10.1101/cshperspect.a006213.

Copper in Alzheimer's disease: a meta-analysis of serum, plasma, and cerebrospinal fluid studies

Ventriglia M, Bucossi S, Panetta V, Squitti R.

J Alzheimers Dis. 2012;30(4):981-4. doi: 10.3233/JAD-2012-120244.

Investigating missing data in Alzheimer disease studies

Schott JM, Bartlett JW.

Neurology. 2012 May 1;78(18):1370-1. doi: 10.1212/WNL.0b013e318253d66b. Epub 2012 Apr 4.

Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease

Kang JH, Vanderstichele H, Trojanowski JQ, Shaw LM.

Methods. 2012 Apr;56(4):484-93. doi: 10.1016/j.ymeth.2012.03.023. Epub 2012 Apr 6.

Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play

Jack CR Jr.

Radiology. 2012 May;263(2):344-61. doi: 10.1148/radiol.12110433.

Amyloid-β(1-15/16) as a marker for γ-secretase inhibition in Alzheimer's disease

Portelius E, Zetterberg H, Dean RA, Marcil A, Bourgeois P, Nutu M, Andreasson U, Siemers E, Mawuenyega KG, Sigurdson WC, May PC, Paul SM, Holtzman DM, Blennow K, Bateman RJ.

J Alzheimers Dis. 2012;31(2):335-41. doi: 10.3233/JAD-2012-120508.

[For a new definition of the Alzheimer's disease]

Dubois B.

Rev Neurol (Paris). 2012 Jun;168(6-7):467-8. doi: 10.1016/j.neurol.2012.03.001. Epub 2012 May 2.

Blood markers of oxidative stress in Alzheimer's disease

Skoumalová A, Hort J.

J Cell Mol Med. 2012 Oct;16(10):2291-300. doi: 10.1111/j.1582-4934.2012.01585.x.

[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia]

Croisile B, Auriacombe S, Etcharry-Bouyx F, Vercelletto M; National Institute on Aging (u.s.); Alzheimer Association.

Rev Neurol (Paris). 2012 Jun;168(6-7):471-82. doi: 10.1016/j.neurol.2011.11.007. Epub 2012 May 12.

Alzheimer's disease: biological aspects, therapeutic perspectives and diagnostic tools

Di Carlo M, Giacomazza D, San Biagio PL.

J Phys Condens Matter. 2012 Jun 20;24(24):244102. doi: 10.1088/0953-8984/24/24/244102. Epub 2012 May 18.

[Searching for biomarkers to diagnose dementia]

Yanagisawa K.

Nihon Rinsho. 2012 May;70(5):785-9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias